ACG to Invest $200M in U.S. Empty-Capsule Manufacturing Operations

ACG, an integrated provider of solid-dosage solutions, is investing $200 million to establish its first empty-capsule manufacturing operations in the United States.

The initial $100 million will fund a hard-shell capsule facility in Atlanta, Georgia, with a second phase of $100 million planned to expand capacity and capabilities in the region. The investment is expected to create more than 200 jobs, with operations targeted to begin in early 2027.

“This facility strengthens our ties with customers across the region—bringing us closer to them, enabling faster lead times, higher-quality service, and a more resilient, de-risked supply chain. Just as importantly, it lets us respond more quickly and co-develop new innovations through tighter R&D partnerships. It’s been a long time coming, and we’re glad to say it’s here,” said Karan Singh, Managing Director, ACG.

ACG will establish dedicated facilities to manufacture gelatin and vegetarian (HPMC) hard-shell capsules, designed and operated to the highest global standards of quality, safety, and regulatory compliance. The program advances ACG’s ‘Make it Better’ commitment and complements the company’s U.S. ecosystem spanning capsules, barrier packaging materials, processing and encapsulation machinery, visual inspection, and traceability solutions—supported by nationwide sales and service.